Acurx Pharmaceuticals, Inc.ACXPNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank73
Year-over-Year Change
Year-over-year net income growth rate
Percentile
P73
Within normal range
vs 2Y Ago
1.2x
Modest growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 11.28% |
| Q2 2025 | -4.52% |
| Q1 2025 | 22.74% |
| Q4 2024 | 1.41% |
| Q3 2024 | 31.54% |
| Q2 2024 | 5.85% |
| Q1 2024 | 14.40% |
| Q4 2023 | -64.19% |
| Q3 2023 | 9.59% |
| Q2 2023 | -18.68% |
| Q1 2023 | 10.97% |
| Q4 2022 | 7.94% |
| Q3 2022 | -35.15% |
| Q2 2022 | 1.86% |
| Q1 2022 | -1.64% |
| Q4 2021 | 43.41% |
| Q3 2021 | -15.94% |
| Q2 2021 | -171.59% |
| Q1 2021 | -34.88% |
| Q4 2020 | 16.85% |
| Q3 2020 | -43.92% |
| Q2 2020 | 28.59% |
| Q1 2020 | 0.00% |